Clinical profile and prognosis in patients on oral anticoagulation before admission for COVID‐19José Miguel Rivera‐Caravaca, Iván J. Núñez‐Gil, David Vivas et al.|European Journal of Clinical Investigation|2020Cited by 54
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR RegistryMaría Asunción Esteve‐Pastor, Francisco Marı́n, José Miguel Rivera‐Caravaca et al.|European Heart Journal - Cardiovascular Pharmacotherapy|2022Cited by 16
Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID‐19: Insights from the HOPE COVID‐19 RegistryJosé Miguel Rivera‐Caravaca, Francisco Marı́n, Iván J. Núñez‐Gil et al.|International Journal of Clinical Practice|2022Cited by 5
2. TRATAMIENTO QUIRÚRGICO DE LOS MIXOMAS CARDIACOS. EXPERIENCIA DE 4 DÉCADASJosé María Arribas, Sergio Cánovas López, Luis Arribas del Peso et al.|Revista Española de Cardiología|2023Cited by 0
10. EVOLUCIÓN DEL TRATAMIENTO DE LOS MIXOMAS CARDIACOS DURANTE 40 AÑOSJosé María Arribas, Sergio Cánovas López, Manuel Fernández Molina et al.|Revista Española de Cardiología|2023Cited by 0